Fig. 3.
Sensitivity analysis for the risk of cancer associated with the combination of bDMARD and MTX compared with bDMARD monotherapy (secondary objective)
bDMARD: biologic DMARD; CI: confidence interval; HR: hazard ratio.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.